Clinical trial
Intermittent Theta-Burst Transcranial Magnetic Stimulation (TBS) for the Treatment of Parkinson Disease
NCT00753519 is registered in ClinicalTrials.gov with Mark Hallett as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intermittent Theta-Burst Transcranial Magnetic Stimulation (TBS) for the Treatment of Parkinson Disease
- Lead sponsor
- Mark Hallett
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- September 30, 2009
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.